首页> 外国专利> CONTROL OR ALLEVIATION OF SYMPTOM OR DISORDER CHARACTERIZED BY OR RELATED TO NEUROPEPTIDE Y

CONTROL OR ALLEVIATION OF SYMPTOM OR DISORDER CHARACTERIZED BY OR RELATED TO NEUROPEPTIDE Y

机译:神经肽Y表征或相关的症状或病症的控制或缓解

摘要

PROBLEM TO BE SOLVED: To obtain a medicine for suppressing or alleviating mammalian diseased symptoms or biological disorders characterized by neuropeptide (NPY) or related to NPY, by using a specific compound capable of controlling activity of the NPY by selectively bonding an NPY receptor. SOLUTION: An effective amount of a compound of the formula [R1 is methyl; R3 is phenyl; R2 is NH, (CH2 )3 COOH, piperidinyl or the like] or its salt is administered. A dose is preferably 0.1-15 mg/kg/day. A unit dosage form preferably contains 1-500 mg of the compound of the formula in general. In the case of orally or parenterally administering the compound to an animal, a dose is preferably 0.05-10 mg/kg/day. For example, obesity, hyperphagia, heart-related diseases such as cardiac failure, central nerve system-based diseases such as anxiety, schizophrenia, etc., may be cited as the diseased symptoms or biological disorders treatable by the compound of the formula.
机译:解决的问题:通过使用能够选择性地结合NPY受体来控制NPY活性的特定化合物,获得用于抑制或减轻以神经肽(NPY)为特征或与NPY有关的哺乳动物疾病症状或生物学疾病的药物。溶液:有效量的式[R 1]化合物为甲基;其为甲基。 R 3为苯基; R 2为NH,(CH 2)3 COOH,哌啶基等]或其盐被给予。剂量优选为0.1-15mg / kg /天。一般而言,单位剂型优选包含1-500mg的式的化合物。在对动物口服或肠胃外施用化合物的情况下,剂量优选为0.05-10mg / kg /天。例如,肥胖,多食,与心脏有关的疾病如心力衰竭,基于中枢神经系统的疾病如焦虑症,精神分裂症等,可被引用为可通过该式的化合物治疗的疾病症状或生物学疾病。

著录项

  • 公开/公告号JPH11130774A

    专利类型

  • 公开/公告日1999-05-18

    原文格式PDF

  • 申请/专利权人 PFIZER PROD INC;

    申请/专利号JP19980220638

  • 发明设计人 DOW ROBERT LEE;TATE BONNIE FRANCES;

    申请日1998-08-04

  • 分类号C07D487/04;A61K31/505;

  • 国家 JP

  • 入库时间 2022-08-22 02:36:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号